ijms-logo

Journal Browser

Journal Browser

Kidney Disease: Molecular Insights and Emerging Therapies

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (30 November 2025) | Viewed by 263

Special Issue Editor


E-Mail Website
Guest Editor
Department of Paediatrics, National University of Singapore, Singapore, Singapore
Interests: genetic kidney disease; next-generation sequencing (NGS); nanopore long-read sequencing; transgenic animal models; functional studies (ACMG PS3/BS3 criteria)

Special Issue Information

Dear Colleagues,

Kidney diseases represent a growing global health burden, with limited therapeutic options to halt or reverse disease progression. This special issue aims to highlight the latest discoveries in the molecular mechanisms underlying kidney pathologies and to feature cutting-edge therapeutic strategies under investigation. We welcome original research articles and comprehensive reviews that elucidate key cellular pathways, molecular regulatory networks, and pathogenic variants contributing to the development and progression of kidney diseases.

Particular emphasis will be placed on translational studies exploring innovative therapeutic approaches, including gene therapy platforms such as adeno-associated virus (AAV) vectors, CRISPR/Cas-based genome editing, RNA-targeting therapies, and other molecular interventions. Studies employing advanced experimental models—such as transgenic animals, organoids, or patient-derived cell systems—to validate novel targets and therapeutic mechanisms are especially encouraged. By bridging molecular insights with therapeutic innovation, this special issue seeks to foster the development of precise and effective treatments for both inherited and acquired forms of kidney disease.

Dr. Yaochun Zhang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • kidney disease
  • molecular mechanism
  • precision medicine
  • translational nephrology
  • targeted molecular therapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

12 pages, 354 KB  
Case Report
Dynamic Changes in Oxidative Stress Biomarkers in a Child with Idiopathic Nephrotic Syndrome: A Longitudinal Case Study
by Joško Osredkar and Matjaž Kopač
Int. J. Mol. Sci. 2026, 27(1), 216; https://doi.org/10.3390/ijms27010216 (registering DOI) - 24 Dec 2025
Abstract
Idiopathic nephrotic syndrome (INS) is the most prevalent glomerular illness in children. Even while immunologic processes are well-established, oxidative stress is becoming more widely acknowledged as a significant factor in the etiopathogenesis of illness. Assessing its activity and treatment response may be made [...] Read more.
Idiopathic nephrotic syndrome (INS) is the most prevalent glomerular illness in children. Even while immunologic processes are well-established, oxidative stress is becoming more widely acknowledged as a significant factor in the etiopathogenesis of illness. Assessing its activity and treatment response may be made easier with the use of trustworthy, non-invasive indicators to track redox balance. We report on the oxidative stress levels of a 10.7-year-old boy with INS with five clinical time points in one year. The FRAS5 analyzer was used to calculate the oxidative stress index (OSI), plasma antioxidant capacity (PAT) and derivatives of reactive oxygen metabolites (d-ROMs) as biomarkers. A 4-tier oxidative state classification scheme based on d-ROM and PAT thresholds was used to interpret the values. The patient had low antioxidant defense, moderate oxidative and increased OSI at relapses, a positive transition to reduced oxidative burden and enhanced defense during remission. The order of events showed a dynamic redox response associated with glucocorticoid (GC) medication and disease activity. The potential value of d-ROM, PAT, and OSI as dynamic biomarkers for tracking disease activity, response to treatment and residual oxidative burden in pediatric INS is supported by this case. To confirm their function in more comprehensive clinical decision-making, more research is required. Full article
(This article belongs to the Special Issue Kidney Disease: Molecular Insights and Emerging Therapies)
Show Figures

Figure 1

Back to TopTop